Published Medical TLR4 Antagonist Preserves commensal bacteria and accelerates patient recovery time. By Imperial Innovations
Published Medical Controlled Delivery of Agonist It shows significant synergy leading to an enhanced activation of two subsets of Dendritic cells, inducing T-cell response at the tumor site in an aggressive melanoma cancer model. By Harvard University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
